Percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation: who should receive it in current clinical practice?
pLAAC has a growing role in patients with atrial fibrillation with moderate to high stroke risk and contraindication to OAC. Multiple randomized trials are currently underway in different patient populations, which may expand the role of pLAAC.
Authors
- Marc-André d’Entremont (ORCID: https://orcid.org/0000-0002-1432-7384)
- Sanjit S. Jolly (ORCID: https://orcid.org/0000-0003-2329-2504)
- Jeff Healy
Institutions
- Centre Hospitalier Universitaire de Sherbrooke (CA)
- Population Health Research Institute (CA)
- Hamilton Health Sciences (CA)
- McMaster University (CA)
Publication Details
- Journal
- Current Opinion in Cardiology
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1097/hco.0000000000001270
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00